The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Link
https://link.springer.com/content/pdf/10.1007/s00296-023-05334-1.pdf
Reference33 articles.
1. González-Melado FJ, Di Pietro ML (2020) The vaccine against COVID-19 and institutional trust. Enfermedades Infecc Microbiol Clin Engl Ed 39:510–515. https://doi.org/10.1016/j.eimc.2020.08.001
2. Koch T, Fathi A, Addo MM (2021) The COVID-19 vaccine landscape. Adv Exp Med Biol 1318:549–573. https://doi.org/10.1007/978-3-030-63761-3_31
3. Xu C, Yi Z, Cai R, Chen R, Thong BY-H, Mu R (2021) Clinical outcomes of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis of global data. Autoimmun Rev 20:102778. https://doi.org/10.1016/j.autrev.2021
4. Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scirè CA et al (2021) Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 80:930–942. https://doi.org/10.1136/annrheumdis-2020-219498
5. Bijlsma JW, EULAR COVID-19 Task Force (2022) EULAR 2021 updated viewpoints on SARS-CoV-2 vaccination in patients with RMDs: a guidance to answer patients’ questions. Ann Rheum Dis 81:786–788. https://doi.org/10.1136/annrheumdis-2021-221965
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Coronavirus disease 2019 vaccination in patients with rheumatic diseases: A bibliometric‐based analysis of trends;Rheumatology & Autoimmunity;2024-06
2. Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data;Rheumatology International;2023-12-24
3. SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey;Rheumatology International;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3